Colon polyp of endoscopic treatment adapttion
Conditions
Interventions
Hot Snare Polypectomy (C-HSP)
Cold snare polypectomy(CSP)
Sponsors
Southern Tohokou General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Persons whose age at agreement acquisition is between 20 and 80 years old. 2) Person who has a sessile or flat type lesion of 6 mm or more and less than 10 mm in the colonoscopy exam performed at our hospital in the past year. 3) Person who got document agreement by his/her free will after fully understanding after participating in this research. 4) People whose PS (ECOG) is either 0 or 1. 5) Clinical inspection test within 28 days of registration date, who satisfy all the conditions as below. Number of platelets >= 100,000/microL Serum creatinine value <= 2.0 mg/dL PT (%) >= 40% or more. 6) Person who can track the progress of 28 days after treatment.
Exclusion criteria
Exclusion criteria: 1) Person who has registered history in this exam. 2) Persons diagnosed with inflammatory bowel disease, colon polyposis. 3) Lesions of 10 mm or more, lesions suspected of cancer, those who are known to have pedunculated and depressed lesions in advance. 4) Persons undergoing continuous systemic administration of steroids and antithrombotics. 5) Persons with blood coagulation function disorder. 6) During pregnancy Persons who are likely to become pregnant or who are lactating. 7) Persons who are merging psychosis or psychiatric symptoms and who seem to be difficult to participate in the exam. 8) Persons who have active bacterial and fungal infection complications (having a fever> 38.5 degrees and suggesting bacterial infection by imaging diagnosis or bacteriologic examination). 9) Persons who are merging uncontrolled high-blood pressure. 10) Persons who have respiratory diseases requiring sustained oxygen administration. 11) Persons who are in dialysis. 12) Others who judged that the doctor in charge is inappropriate as the research subject
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The ratio of completely resected the muscularis mucosa just under the lesion by the pathological specimen | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Ratio of acknowledging CSDPs after resection 2) 3) 4) 5) Average time of hemostasis 6) Ratio of bleeding which was required intraoperative hemostasis just after of polypectomy 7) Incidence of uncontrolled intraoperative bleeding 8) Ratio of postoperative bleeding 9) Ratio of adverse event occurrence | — |
Countries
Japan
Contacts
Public ContactMasatake Tamaki
Japan Society of Clinical Research Director
Outcome results
None listed